Magnesium Sulfate: 90 years to become the standard of care, maybe another 40 years for Vitamin D
Asked Claude AI about how long it took for loading dose - Sept 2026
Your suspicion is right, and the history is a useful parallel for vitamin D. It took about 90 years from the first use of magnesium sulfate for eclampsia (1906) to the randomized trial that made it the standard of care worldwide (1995). The timeline also split sharply by country: US obstetricians adopted it on case series by the 1950s–60s, while the UK and much of Europe waited for an RCT, about 40 years later.
| Year | Milestone | Source |
|---|---|---|
| 1906 | Horn gives magnesium sulfate intrathecally (into the spinal canal) for eclampsia | [Lucas 1995 NEJM] |
| 1925 | Lazard reports IV magnesium sulfate for eclampsia | [AJOG 2025 history] |
| 1926 | Dorsett uses intramuscular injections, borrowed from tetanus treatment | [Lucas 1995 NEJM] |
| 1933 | Lazard reports 575 women treated IV at Los Angeles General Hospital, all at small doses | [Lucas 1995 NEJM] |
| 1945 | Eastman and Steptoe (Johns Hopkins) use a 10 g IM loading dose in 300 cases of eclampsia | [AJOG 2025 history] |
| 1955 | Pritchard formalizes the IM regimen at Parkland Hospital, Dallas | [Lucas 1995 NEJM] |
| 1964–1966 | Zuspan formalizes the IV regimen (4 g IV load, then 1 g/hour) | [Lucas 1995 NEJM] |
| 1960s–1970s | Becomes the de facto US standard without any RCT | [Wikidoc] |
| 1988 | US neurologists publish "No, magnesium sulfate should not be used in treating eclamptic seizures" | Kaplan et al., Arch Neurol 1988;45:1361 |
| Early 1990s | UK obstetricians mostly use diazepam or phenytoin; a 1992 survey found only a small minority used magnesium | Hutton et al., BMJ 1992 |
| 1995 | Collaborative Eclampsia Trial (1,687 women, multicenter): magnesium beats diazepam and phenytoin | Eclampsia Trial Collaborative Group, Lancet 1995;345:1455 |
| 1995 | Lucas (Parkland) RCT: magnesium beats phenytoin for preventing eclampsia | [Lucas 1995 NEJM] |
| 1995–2000 | UK and European practice switches within a few years of the trial | — |
| 2002 | Magpie Trial (about 10,000 women): magnesium halves eclampsia risk in preeclampsia | Magpie Trial Collaborative Group, Lancet 2002;359:1877 |
| 2008–2010 | New use: fetal neuroprotection against cerebral palsy (BEAM trial, then ACOG Committee Opinion 455) | Rouse et al., NEJM 2008;359:895 |
| 2011 | WHO recommends magnesium sulfate for severe preeclampsia and eclampsia | WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia, 2011 |
| Today | Still underused in many low- and middle-income countries, over 100 years after first use | — |
A few points bear directly on your vitamin D argument.
The US adopted it on observational data. The US standard came from case series such as Lazard's 575 women and Pritchard's Parkland experience, with no randomized trial. This was accepted practice in obstetrics then and is harder now, but it shows that large, consistent observational results have moved practice before.
One large RCT changed Europe in about five years. Opinion had been stuck for decades. The Collaborative Eclampsia Trial was large, multicenter, and funded independently of any company, since magnesium sulfate is cheap and unpatentable. That describes vitamin D exactly. The missing piece is a pregnancy RCT large enough to be decisive, not more small trials.
Specialists outside the field resisted. The 1988 neurologists' paper argued that magnesium isn't a real anticonvulsant, much as some endocrinologists today argue that high vitamin D levels aren't needed.
It was a loading-dose therapy from the start. Eastman's 10 g IM load in 1945 and Zuspan's 4 g IV load both preceded the RCTs. Obstetricians have been giving large loading doses in pregnancy for 80 years.